Tags

Type your tag names separated by a space and hit enter

Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature.
Eur J Gastroenterol Hepatol. 2015 Sep; 27(9):992-1001.EJ

Abstract

Portal hypertension (PH) is one of the most important causes of morbidity and mortality in patients with chronic liver disease. PH measurement is crucial to stage and predict the clinical outcome of liver cirrhosis. Measurement of hepatic vein pressure gradient is considered the gold standard for assessment of the degree of PH; however, it is an invasive method and has not been used widely. Thus, noninvasive methods have been proposed recently. We critically evaluated serum markers, abdominal ultrasonography, and particularly liver and spleen stiffness measurement, which represent the more promising methods to stage PH degree and to assess the presence/absence of esophageal varices (EV). A literature search was carried out on MEDLINE, EMBASE, Web of Science, and Scopus for articles and abstracts. The search terms used included 'liver cirrhosis', 'portal hypertension', 'liver stiffness', 'spleen stiffness', 'ultrasonography', and 'portal hypertension serum biomarker'. The articles cited were selected on the basis of their relevance to the objective of the review. The results of available studies indicate that individually, these methods have a mild accuracy in predicting the presence of EV, and thus they cannot substitute endoscopy to predict EV. When these tests were used in combination, their accuracy increased. In addition to the PH staging, several serum markers and spleen stiffness measurement can predict the clinical outcome of liver cirrhosis with a good accuracy, comparable to that of hepatic vein pressure gradient. In the future, noninvasive methods could be used to select patients requiring further investigations to identify the best tailored clinical management.

Authors+Show Affiliations

aDepartment of Gastrointestinal Diseases and Internal Medicine, University of Bologna, Bologna bDepartment of Pediatrics, University of Modena, Modena, Italy.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

26020376

Citation

Colecchia, Antonio, et al. "Liver and Spleen Stiffness and Other Noninvasive Methods to Assess Portal Hypertension in Cirrhotic Patients: a Review of the Literature." European Journal of Gastroenterology & Hepatology, vol. 27, no. 9, 2015, pp. 992-1001.
Colecchia A, Marasco G, Taddia M, et al. Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature. Eur J Gastroenterol Hepatol. 2015;27(9):992-1001.
Colecchia, A., Marasco, G., Taddia, M., Montrone, L., Eusebi, L. H., Mandolesi, D., Schiumerini, R., Di Biase, A. R., & Festi, D. (2015). Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature. European Journal of Gastroenterology & Hepatology, 27(9), 992-1001. https://doi.org/10.1097/MEG.0000000000000393
Colecchia A, et al. Liver and Spleen Stiffness and Other Noninvasive Methods to Assess Portal Hypertension in Cirrhotic Patients: a Review of the Literature. Eur J Gastroenterol Hepatol. 2015;27(9):992-1001. PubMed PMID: 26020376.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature. AU - Colecchia,Antonio, AU - Marasco,Giovanni, AU - Taddia,Martina, AU - Montrone,Lucia, AU - Eusebi,Leonardo H, AU - Mandolesi,Daniele, AU - Schiumerini,Ramona, AU - Di Biase,Anna R, AU - Festi,Davide, PY - 2015/5/29/entrez PY - 2015/5/29/pubmed PY - 2016/5/5/medline SP - 992 EP - 1001 JF - European journal of gastroenterology & hepatology JO - Eur J Gastroenterol Hepatol VL - 27 IS - 9 N2 - Portal hypertension (PH) is one of the most important causes of morbidity and mortality in patients with chronic liver disease. PH measurement is crucial to stage and predict the clinical outcome of liver cirrhosis. Measurement of hepatic vein pressure gradient is considered the gold standard for assessment of the degree of PH; however, it is an invasive method and has not been used widely. Thus, noninvasive methods have been proposed recently. We critically evaluated serum markers, abdominal ultrasonography, and particularly liver and spleen stiffness measurement, which represent the more promising methods to stage PH degree and to assess the presence/absence of esophageal varices (EV). A literature search was carried out on MEDLINE, EMBASE, Web of Science, and Scopus for articles and abstracts. The search terms used included 'liver cirrhosis', 'portal hypertension', 'liver stiffness', 'spleen stiffness', 'ultrasonography', and 'portal hypertension serum biomarker'. The articles cited were selected on the basis of their relevance to the objective of the review. The results of available studies indicate that individually, these methods have a mild accuracy in predicting the presence of EV, and thus they cannot substitute endoscopy to predict EV. When these tests were used in combination, their accuracy increased. In addition to the PH staging, several serum markers and spleen stiffness measurement can predict the clinical outcome of liver cirrhosis with a good accuracy, comparable to that of hepatic vein pressure gradient. In the future, noninvasive methods could be used to select patients requiring further investigations to identify the best tailored clinical management. SN - 1473-5687 UR - https://www.unboundmedicine.com/medline/citation/26020376/Liver_and_spleen_stiffness_and_other_noninvasive_methods_to_assess_portal_hypertension_in_cirrhotic_patients:_a_review_of_the_literature_ L2 - https://doi.org/10.1097/MEG.0000000000000393 DB - PRIME DP - Unbound Medicine ER -